Lung Cancer (Diagnosis)
Conditions
Brief summary
During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.
Interventions
DIAGNOSTIC_TESTEBUS-TBNA
During EBUS staging, the needle well be changed between all lymph node stations in a first round. The EBUS staging will be repeated without the change of the needle between the lymph node stations.
Sponsors
University of Vienna
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Pulmonary lesion suspicious for lung cancer or histologically confirmed lung cancer * indication for mediastinal staging
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Agreement between the two rounds of EBUS staging | 18 months |
Countries
Austria
Contacts
CONTACTDaniela Gompelmann
Outcome results
None listed